At a glance
ClinicalIndex Comparison RecordN/ACompleted· 303 enrolled
Drug / intervention
Questionnaire +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Post-Marketing Surveillance For Safety And Adherence To Treatment Of Enbrel In Adults With Psoriatic Arthritis In Belgium
In Brief
An observational study evaluating Questionnaire for Arthritis, Psoriatic. Completed, enrolled 303 participants across 1 site.
Detailed Summary
The aim of this study is to evaluate if the data obtained in controlled clinical trials are confirmed when Enbrel is used in usual clinical practice in Belgium according to local reimbursement criteria.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsArthritis, Psoriatic
CountriesBelgium
Collaborators--
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2004
First PostedJul 2009
Primary CompletionApr 2012
TodayJul 2026
First PostedJul 13, 2009
Enrollment StartOct 1, 2004
Primary CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 7.5 yearsPosted 17.0 years ago
Interventions
Questionnaireother
This is a non-interventional study
Questionnaireother
This is a non-interventional study